Oncology/Hematology
News, opinions and meeting coverage in oncology/hematology.
FDA Panel Puts Brakes on Anti-PARP Drug
WASHINGTON -- Approval of a PARP inhibitor for patients with advanced ovarian cancer should await results of an ongoing clinical trial that has the potential to answer questions about the drug's safety and efficacy, according to an FDA advisory committee that voted against immediate approval.
Jun 25, 2014
Medtronic's Infuse Moves From Operating Room to Courtroom
An investigative series by Ƶ/Milwaukee Journal Sentinel has been tracking the spinal fusion device called Infuse in a 4-year-long series and now reports how a flawed FDA system for device approval may have led to a long string of adverse events culminating in thousands of liability suits.
May 18, 2014
OncoBlog: Driving the CAR to a Cancer Cure?
Is immunotherapy with chimeric antigen receptor (CAR)-directed T cells the "next big thing" in oncology? Presentations and discussion at a recent conference suggest the technology has considerable promise -- but will it qualify as a breakthrough? OncoBlog is a blog by the Ƶ
Medical Today staff for readers with an interest in oncology. This post comes from Charles Bankhead.
Dec 19, 2013